Two of the six vouchers in the second round went to GLP-1 drugs: Novo Nordisks semaglutide, directed toward a higher-dose formulation of Wegovy, and Eli Lillys orforglipron, an oral non-peptide small molecule that had not yet received FDA approval
While you don't need to be as rigidly adherent to a diet as you would if it was the only way you were trying to improve your health, working to eat better is going to be better for you over time
[1] [5] The SmPC also highlights the risk of gallbladder disorders, including cholelithiasis and cholecystitis
Although the difference in the incidence of MACE between GLP-1 RA and comparators failed to show statistical significance (Mantel-Haenzel odds ratio, 0.78
Take this medicine in the dose and duration as advised by your doctor
PeptIQ lets you log each compound, set reminders, and track protocol adherence week over week